Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
First Tracks Biotherapeutics, Inc. - Ordinary Shares
(NQ:
TRAX
)
34.05
+2.20 (+6.91%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about First Tracks Biotherapeutics, Inc. - Ordinary Shares
First Tracks’ ANB033 Clears Key Phase Ib Celiac Disease Study Goals
↗
Today 13:02 EDT
First Tracks Biotherapeutics (NASDAQ:TRAX) reported top-line results from the first cohort of its Phase Ib study of ANB033 in celiac disease, saying the investigational CD122 antagonist met histologic...
Via
MarketBeat
These stocks are gapping in today's session
↗
Today 10:30 EDT
Via
Chartmill
These stocks are moving in today's pre-market session
↗
Today 8:30 EDT
Via
Chartmill
First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease
Today 7:00 EDT
From
First Tracks Biotherapeutics Inc
Via
GlobeNewswire
First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
October 11, 2026
From
First Tracks Biotherapeutics Inc
Via
GlobeNewswire
Which stocks are gapping on Wednesday?
↗
September 02, 2026
Via
Chartmill
First Tracks Biotherapeutics Announces Participation in September Investor Conferences
August 26, 2026
From
First Tracks Biotherapeutics Inc
Via
GlobeNewswire
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
From
First Tracks Biotherapeutics Inc
Via
GlobeNewswire
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
July 27, 2026
Via
Chartmill
These stocks that are showing activity before the opening bell on Monday.
↗
July 27, 2026
Via
Chartmill
Which stocks are moving before the opening bell on Thursday?
↗
July 23, 2026
Via
Chartmill
Which stocks are experiencing notable movement on Thursday?
↗
July 09, 2026
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
July 09, 2026
Via
Chartmill
First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences
May 21, 2026
From
First Tracks Biotherapeutics Inc
Via
GlobeNewswire
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
From
First Tracks Biotherapeutics Inc
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
